Skip to main content

HUM$304.10

Humana Inc.

Last Updated
May 21, 2026about 1 month ago
Moat & Trend
Narrow Moat Negative
Management
Competent
AI Impact
0 Neutral
Competitive Radar

Moat Score

53/100

Executive Summary

Humana has a real but limited moat centered on scale in Medicare Advantage, long-standing relationships with providers and government payers, and meaningful member switching friction once coverage, doctors, and benefits are embedded. Its strongest positions are in senior-focused managed care and military contracts, where administrative complexity and local density can support retention. However, the business lacks strong network effects, pricing power is constrained by regulation, and competitors can still attack with aggressive bidding and richer benefits. Recent pressure from medical cost trends, reimbursement scrutiny, and contract economics suggests the moat is under strain. Overall, Humana remains a Narrow Moat company, but the moat is weakening rather than strengthening.

Sign in to see the full analysis

The Strategic Factor Breakdown, Management Quality Assessment, and AI Impact Assessment are available to registered users — it's free.

Last Updated
May 21, 2026about 1 month ago
Target Price
$248.25-18.4% Downside
Analyst Consensus
Hold20 analysts
FAIR VALUE
$631.00+107.5% Upside
Financial Strength

Financial Score

54/100

Executive Summary

Humana’s most notable strength is its solid balance sheet, with substantial investment assets, improving cash, and manageable leverage supporting a $18.6 billion equity base. However, that strength contrasts with a weaker operating profile: revenue has grown, but underwriting-heavy earnings have deteriorated, with margins compressing and net income falling faster than sales. Cash flow remains positive but has become volatile and much less efficient, while returns on equity, assets, and capital have trended lower. Forecasts suggest some earnings recovery and margin repair in 2027, but near-term visibility is mixed. Overall, Humana presents a financially resilient insurer with adequate liquidity and balance-sheet depth, offset by mediocre profitability and cash-generation trends, consistent with its mid-range ratings.

Income Statement
Balance Sheet
Cash Flow Statement
Key Ratios
Growth & Forecast
Fair Value Estimation

Sign in to see the full analysis

The Income Statement, Balance Sheet, Cash Flow, Key Ratios, Forecast, and Fair Value analysis are available to registered users — it's free.

Sign In to Run AI-Powered Technical Analysis

Create a free account to run a fresh technical analysis across three timeframes — short, medium, and long term.

Disclaimer: The analysis on this page is generated by AI and is provided for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell any security. Always conduct your own due diligence and consult a qualified financial adviser before making any investment decisions.